About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

What Is Allogeneic Cell Therapy, And What’s Driving This Market’s 25%+ Annual Global Growth?

PHOENIX, AZ / ACCESSWIRE / August 24, 2023 / Biotechnology company Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) seems to be witnessing success in the allogeneic cell therapy market.

Creative Medical Technology Holdings, Inc., Thursday, August 24, 2023, Press release picture

In Q4 2022, the company - best known for its regenerative approach to immunotherapy, endocrinology, urology, gynecology and orthopedics - made a significant announcement regarding the successful development of an allogeneic cell line known as AlloStem™. AlloStem™ is a cell line that is derived from human perinatal tissue and includes a Master Cell Bank and a Drug Master File. Following FDA approval, the program - referred to as CELZ-201 - is now being utilized in an early type 1 diabetes clinical trial. It will continue to undergo development for the treatment of both type 1 and type 2 Diabetes.

The company has also started using its AlloStem™ line to help treat chronic back pain for its StemSpine® procedure. It reports that this combination resulted in a greater than 90% reduction in narcotic usage associated with chronic back pain, a greater than 80% reduction in pain score and a greater than 50% reduction in the Oswestry score in patients treated with AlloStem™.

So what is allogeneic cell therapy? Allogeneic cell therapy is a type of treatment that uses cells donated by a healthy person to treat a patient with an otherwise untreatable disease. These cells can come from different sources, including bone marrow, blood or umbilical cord blood. These types of therapies have shown immense promise in the medical community.

Allogeneic cell therapy can provide patients with a potentially curative treatment option where other traditional therapies have been unsuccessful. As a relatively new field, research into allogeneic cell therapies is ongoing, and the future seems promising for patients who suffer from these diseases. Companies like Argan Inc are also exploring the potential benefits of allogeneic cells.

With the necessary endorsement from the FDA and an ongoing clinical trial, Creative Medical Technology's recent developments set the stage for innovative treatment options that could significantly improve the lives of patients grappling with diabetes and other diseases. The global market size for allogeneic cell therapy was $255.6 million in 2022, and it is expected to grow at a CAGR of 27.4% from 2023 to 2030, highlighting the value of ongoing research. As the company remains steadfast in its commitment to medical innovation, its efforts have the potential to yield enhanced health outcomes for individuals worldwide.

Featured photo by Diabetesmagazijn.nl on Unsplash.

Contact:

Apex The Equity Group Inc., Devin Sullivan
dsullivan@equityny.com

SOURCE: Creative Medical Technology Holdings, Inc.



View source version on accesswire.com:
https://www.accesswire.com/776624/What-Is-Allogeneic-Cell-Therapy-And-Whats-Driving-This-Markets-25-Annual-Global-Growth

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.